Evidence map›Paper›PMID 32732264›Full record

ArticleGenome research2020

Cross-species analysis of enhancer logic using deep learning.

Liesbeth Minnoye, Ibrahim Ihsan Taskiran, David Mauduit, Maurizio Fazio, Linde Van Aerschot, Gert Hulselmans, Valerie Christiaens, Samira Makhzami, Monika Seltenhammer, Panagiotis Karras and 9 more

Abstract read
In one paragraph

Article in Genome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed.

  1. Article
  2. UnlockingNAR genomics and bioinformatics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Liesbeth Minnoye *VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.ORCID 0000-0002-0898-2817
Ibrahim Ihsan Taskiran *VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.ORCID 0000-0002-5077-5264
David MauduitVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
Maurizio FazioHoward Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Linde Van AerschotVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
Gert HulselmansVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
Valerie ChristiaensVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
Samira MakhzamiVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
Monika SeltenhammerCenter for Forensic Medicine, Medical University of Vienna, 1090 Vienna, Austria.
Panagiotis KarrasVIB-KU Leuven Center for Cancer Biology, 3000 Leuven, Belgium.
Aline PrimotCNRS-University of Rennes 1, UMR6290, Institute of Genetics and Development of Rennes, Faculty of Medicine, 35000 Rennes, France.
Edouard CadieuCNRS-University of Rennes 1, UMR6290, Institute of Genetics and Development of Rennes, Faculty of Medicine, 35000 Rennes, France.
Ellen van RooijenHoward Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Jean-Christophe MarineVIB-KU Leuven Center for Cancer Biology, 3000 Leuven, Belgium.
Giorgia EgidyUniversité Paris-Saclay, INRA, AgroParisTech, GABI, 78350 Jouy-en-Josas, France.
Ghanem-Elias GhanemInstitut Jules Bordet, Université Libre de Bruxelles, 1000 Brussels, Belgium.
Leonard ZonHoward Hughes Medical Institute, Stem Cell Program and the Division of Pediatric Hematology/Oncology, Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.
Jasper WoutersVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.ORCID 0000-0002-7129-2990
Stein AertsVIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.ORCID 0000-0002-8006-0315

Funding

Transcriptional mechanisms and melanomaP01CA163222 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Kai W Wucherpfennig · 2013 to 2026
$25.3M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
NCI NIH HHS P01 CA163222NCI NIH HHS R01 CA103846
6 · The paper itself

Abstract

Deciphering the genomic regulatory code of enhancers is a key challenge in biology because this code underlies cellular identity. A better understanding of how enhancers work will improve the interpretation of noncoding genome variation and empower the generation of cell type-specific drivers for gene therapy. Here, we explore the combination of deep learning and cross-species chromatin accessibility profiling to build explainable enhancer models. We apply this strategy to decipher the enhancer code in melanoma, a relevant case study owing to the presence of distinct melanoma cell states. We trained and validated a deep learning model, called DeepMEL, using chromatin accessibility data of 26 melanoma samples across six different species. We show the accuracy of DeepMEL predictions on the CAGI5 challenge, where it significantly outperforms existing models on the melanoma enhancer of

Indexed as

AnimalsComputational BiologyDeep LearningDogsEnhancer Elements, GeneticGene Expression Regulation, NeoplasticHorsesHumansMelanomaMiceSwineZebrafish

Identifiers

PMID32732264
PMCPMC7706731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.